SCHEMBL315985

SCHEMBL315985

CCOC(CC)(CC(=O)O)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
ALDH1A1 P00352 2/20 0.36
HMGCR P04035 1/20 0.36
CHRM1 P11229 1/20 0.36
TBXA2R P21731 1/20 0.36
ADRA1A P35348 1/20 0.36
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
THRB P10828 1/20 0.32
KMT2A Q03164 1/20 0.32
FFAR3 O14843 1/20 0.32
EGLN1 Q9GZT9 1/20 0.31
SLC13A5 Q86YT5 2/20 0.31
KDM4E B2RXH2 1/20 0.31
FFAR1 O14842 1/20 0.31
CPT2 P23786 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5346342 1.00 CYP2D6 (0.39) CYP2D6TSHRCYP2C19HIF1AALDH1A1
SCHEMBL4329618 0.91 CYP2D6 (0.42) CYP2D6TSHRCYP2C19HIF1AALDH1A1
SCHEMBL3258251 0.86 SOAT1 (0.36) TSHRALDH1A1MEN1CYP1A2THRB
Ethylene Glycol SCHEMBL3734256 0.85 CYP2D6 (0.38) CYP2D6TSHRCYP2C19HIF1AALDH1A1
SCHEMBL28324952 0.84 SOAT1 (0.35) ALDH1A1MEN1CYP1A2THRBKMT2A
1,4-Butanediol SCHEMBL3728797 0.82 CYP4F2 (0.37) CYP2D6TSHRCYP2C19HIF1AALDH1A1
Propylene Glycol SCHEMBL3728972 0.79 TDP1 (0.36) CYP2D6TSHRCYP2C19HIF1AALDH1A1
Di(Hydroxyethyl)Ether SCHEMBL3736317 0.79 ALDH1A1 (0.40) CYP2D6TSHRCYP2C19HIF1AALDH1A1
SCHEMBL8068518 0.78 CYP2C19 (0.44) CYP2D6TSHRCYP2C19HIF1AALDH1A1
SCHEMBL1670467 0.78 MEN1 (0.32) ALDH1A1MEN1CYP1A2THRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3724307-B1 LAUNDRY SURFACTANTS HAVING INHERENT BUILDING CAPACITY DERIVED FROM BIO-BASED HYDROYACIDS AND EPOXIDES; AND PROCESS THEREFORE BATTELLE MEMORIAL INSTITUTE (US) 2025-07-16 EP claimed
EP-2766050-B1 PROCESS FOR THE PREPARATION OF HYPERPOLARIZED DERIVATIVES FOR USE IN MRI ANALYSIS BRACCO IMAGING SPA (IT) 2018-09-05 EP claimed
EP-3350306-A1 RELEASE OF ODORIFEROUS SUBSTANCES FROM MICROCAPSULES Henkel AG & Co. KGaA (DE) 2018-07-25 EP claimed
EP-2203181-B1 AN ORALLY ADMINISTERABLE SOLID PHARMACEUTICAL COMPOSITION AND A PROCESS THEREOF BIOCON LTD (IN) 2018-02-14 EP claimed
EP-3233821-A1 ORTHOFORMIC ACID ESTERS AS PRO-FRAGRANCES Henkel AG & Co. KGaA (DE) 2017-10-25 EP claimed
WO-2017045893-A1 RELEASE OF ODORIFEROUS SUBSTANCES FROM MICROCAPSULES HENKEL AG & CO. KGAA (DE) 2017-03-23 WO claimed
EP-2568974-B1 ALCOHOL-RESISTANT ORAL PHARMACEUTICAL FORM ETHYPHARM SA (FR) 2017-01-04 EP claimed
US-9511154-B2 Process for the preparation of hyperpolarized derivatives for use in MRI analysis BRACCO IMAGING S.P.A. (IT) 2016-12-06 US claimed
US-9468633-B2 Oral controlled release dosage form ANDRX PHARMACEUTICALS, INC. (US) 2016-10-18 US claimed
US-9387178-B2 Modified release tranexamic acid formulation ACTAVIS, INC. (US) 2016-07-12 US claimed
EP-1333816-A2 MEDICINE BASED ON ANTI-HYPERGLYCAEMIC MICROCAPSULES WITH PROLONGED RELEASE AND METHOD FOR PREPARING SAME FLAMEL TECHNOLOGIES (FR) 2003-08-13 EP claimed
EP-1283701-A1 A COATING COMPOSITION FOR FACILITATING CONTROLLED RELEASE Ranbaxy Laboratories Limited (IN) 2003-02-19 EP claimed
WO-2002094285-A1 SINGLE-DAILY-DOSE ANTIDIABETIC ORAL PHARMACEUTICAL FORM COMPRISING A BIGUANIDE AND AT LEAST ANOTHER ACTIVE PRINCIPLE FLAMEL TECHNOLOGIES (FR) 2002-11-28 WO claimed
WO-2002039984-A2 MEDICINE BASED ON ANTI-HYPERGLYCAEMIC MICROCAPSULES WITH PROLONGED RELEASE FLAMEL TECHNOLOGIES (FR) 2002-05-23 WO claimed
WO-2001087269-A1 A COATING COMPOSITION FOR FACILITATING CONTROLLED RELEASE RANBAXY LABORATORIES LIMITED (IN) 2001-11-22 WO claimed
EP-0106443-B1 PHARMACEUTICAL ORAL-CONTROLLED RELEASE MULTIPLE-UNITS FORMULATION BENZON PHARMA A/S (DK) 1991-07-17 EP claimed
EP-0066864-B1 NEW CHEWING GUM BASE AND THEIR USE IN A CHEWING GUM NABISCO BRANDS, Inc. (US) 1986-03-05 EP claimed
US-4574080-A TIME RELEASE DRUGS A/S ALFRED BENZON (DK) 1986-03-04 US claimed
US-4572833-A COATING WITH MIXTURE OF SOLVENT, FILM-FORMING SUBSTANCE AND HYDROPHOBIC SUBSTANCE A/S ALFRED BENZON (DK) 1986-02-25 US claimed
EP-0106443-A2 Pharmaceutical oral-controlled release multiple-units formulation BENZON PHARMA A/S (DK) 1984-04-25 EP claimed